WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Return
46.92%
This Quarter Return
+23.81%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$36.8B
AUM Growth
+$8.29B
(+29%)
Cap. Flow
+$2.29B
Cap. Flow
% of AUM
6.23%
Top 10 Holdings %
Top 10 Hldgs %
65.5%
Holding
199
New
20
Increased
141
Reduced
29
Closed
6
Top Buys
| 1 |
HDFC Bank
HDB
|
$701M |
| 2 |
Synopsys
SNPS
|
$265M |
| 3 |
Nike
NKE
|
$257M |
| 4 |
Mercado Libre
MELI
|
$176M |
| 5 |
Church & Dwight Co
CHD
|
$134M |
Top Sells
| 1 |
Crown Castle
CCI
|
$229M |
| 2 |
Illumina
ILMN
|
$199M |
| 3 |
Cooper Companies
COO
|
$165M |
| 4 |
Boston Scientific
BSX
|
$139M |
| 5 |
ANSS
Ansys
ANSS
|
$72M |
Sector Composition
| 1 | Technology | 32.16% |
| 2 | Healthcare | 21.97% |
| 3 | Consumer Discretionary | 18.62% |
| 4 | Financials | 12.33% |
| 5 | Industrials | 9.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Rexford Industrial Realty
REXR
$9.96B
| $8.38M | 0.02% |
170,709
+514
| +0.3% | +$25.2K |
|
127
Repligen
RGEN
$6.78B
| $8.2M | 0.02% |
42,804
-14,783
| -26% | -$2.83M |
|
|
EVOP
128
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $7.71M | 0.02% |
285,553
+873
| +0.3% | +$23.6K |
|
129
Iovance Biotherapeutics
IOVA
$796M
| $7.2M | 0.02% |
155,090
-57,327
| -27% | -$2.66M |
|
130
Surgery Partners
SGRY
$2.87B
| $6.92M | 0.02% |
238,513
-124,979
| -34% | -$3.63M |
|
|
BHVN
131
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $6.91M | 0.02% |
80,658
+14,989
| +23% | +$1.28M |
|
132
Tandem Diabetes Care
TNDM
$837M
| $6.9M | 0.02% |
72,108
+198
| +0.3% | +$18.9K |
|
133
Ligand Pharmaceuticals
LGND
$3.27B
| $6.73M | 0.02% |
108,433
+46,225
| +74% | +$2.87M |
|
134
Maximus
MMS
$4.99B
| $6.63M | 0.02% |
90,555
-140
| -0.2% | -$10.2K |
|
135
Kodiak Sciences
KOD
$452M
| $6.56M | 0.02% |
44,654
-33,322
| -43% | -$4.9M |
|
|
TPTX
136
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.5M | 0.02% |
53,316
+17,976
| +51% | +$2.19M |
|
|
CCF
137
DELISTED
Chase Corporation
CCF
| $6.45M | 0.02% |
63,896
+1,154
| +2% | +$117K |
|
|
NSTG
138
DELISTED
NanoString Technologies, Inc.
NSTG
| $6.36M | 0.02% |
+95,049
| New | +$6.36M |
|
139
Emergent Biosolutions
EBS
$407M
| $6M | 0.02% |
66,979
+1,135
| +2% | +$102K |
|
140
Axsome Therapeutics
AXSM
$6.21B
| $5.88M | 0.02% |
72,107
+197
| +0.3% | +$16.1K |
|
141
Halozyme
HALO
$8.59B
| $5.66M | 0.02% |
132,450
+401
| +0.3% | +$17.1K |
|
|
142
Cooper Companies
COO
$13.5B
| $5.52M | 0.02% |
60,736
-1,818,808
| -97% | -$165M |
|
143
Rocket Pharmaceuticals
RCKT
$349M
| $5.22M | 0.01% |
+95,135
| New | +$5.22M |
|
144
Insmed
INSM
$30.1B
| $5.2M | 0.01% |
156,079
+499
| +0.3% | +$16.6K |
|
145
Regis Corp
RGS
$54.8M
| $5.07M | 0.01% |
27,566
+84
| +0.3% | +$15.4K |
|
|
CCXI
146
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.59M | 0.01% |
74,059
-49
| -0.1% | -$3.03K |
|
147
Wingstop
WING
$8.62B
| $4.52M | 0.01% |
34,116
+30
| +0.1% | +$3.98K |
|
148
Acadia Pharmaceuticals
ACAD
$4.3B
| $3.93M | 0.01% |
73,534
+415
| +0.6% | +$22.2K |
|
149
CryoPort
CYRX
$443M
| $3.81M | 0.01% |
+86,783
| New | +$3.81M |
|
150
Tradeweb Markets
TW
$26.3B
| $3.75M | 0.01% |
59,966
+25,675
| +75% | +$1.6M |
|